ArticleJournal of medical virology2021

Tocilizumab for the treatment of adult patients with severe COVID-19 pneumonia: A single-center cohort study.

Mario Fernández-Ruiz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.